2026 BIO Asia: Next-Gen 3D Cell Culture & Exosome Solutions by LIS TECH & GeniCore Biotech
Exhibitor: LIS TECH CO., LTD. / GENICORE BIOTECH
Date: 2026-06-04
Booth No.: M1231
LIS TECH and GeniCore Biotech to Present Integrated Platform for Cell Culture, Exosome Research, and 3D Biomedical Applications at 2026 BIO Asia–Taiwan
Advancing a New Era of Regenerative Medicine and Exosome Research
At the upcoming 2026 BIO Asia–Taiwan Exhibition, LIS TECH, in collaboration with GeniCore Biotech, will showcase a fully integrated workflow spanning cell culture, sample preparation, and downstream analysis. This comprehensive platform is designed to enhance research efficiency, improve experimental reproducibility, and accelerate the advancement of regenerative medicine and exosome research.
IK INABATA Solallis Bio™: Building a Stable Foundation for Cell Culture
Cell quality serves as a critical starting point for both regenerative medicine and exosome research.
At this year’s exhibition, LIS TECH will present the IK INABATA Solallis Bio™ series, including MSC-specific culture media, exosome collection media, and organic solvent-free cryopreservation solutions. These products are designed to improve cell culture stability, enhance cell viability, and ensure consistent downstream performance.
Among them, the Solallis Bio™ exosome collection medium enhances exosome yield while reducing background contamination in culture conditions, enabling researchers to obtain higher-purity exosome samples during downstream purification workflows.
In addition, the organic solvent-free cryopreservation solution is formulated with intravenously compatible components and contains no organic solvents, offering improved safety for cell handling and broader applicability in regenerative medicine applications.
SUMITOMO BAKELITE Sbio™: Advanced 3D Cell Culture and Organoid Models
Compared with conventional 2D culture systems, 3D cell culture and organoid technologies better replicate the in vivo cellular microenvironment and cell–cell interactions.
LIS TECH presents the SUMITOMO BAKELITE Sbio™ platform, offering a comprehensive solution for 3D cell culture and organoid research.
The PrimeSurface™ 3D culture plates feature different bottom surface designs that enable the formation of highly uniform and reproducible spheroids. Researchers can adjust spheroid compaction levels according to experimental needs, making the system widely applicable in organoid development, drug screening, cancer research, and cell function analysis.
The BioStellar™ organoid platform integrates microfluidic technology with multi-cell co-culture systems, enabling the construction of more physiologically relevant 3D tissue models that better mimic in vivo environments and improve translational research value.
ExoPERT: High-Purity Exosome Isolation Solution
Exosomes have become a rapidly growing focus in regenerative medicine, disease research, and biomarker discovery.
LIS TECH introduces the ExoPERT exosome purification platform from Korea, which includes the Exo-i purification column and the ExoTractor automated isolation system. The Exo-i system is based on proprietary dual-layer size exclusion chromatography (Dual SEC), effectively removing proteins and lipoproteins to achieve higher exosome purity and improved experimental reproducibility.
The ExoTractor automated system further streamlines the isolation process, enhancing workflow consistency and operational efficiency.
GeniCore Biotech Genimer™ Aptamer Technology: A New Approach for Exosome Analysis
High-quality analytical tools are essential for robust exosome research workflows.
In collaboration with GeniCore Biotech, LIS TECH presents Genimer™ aptamer-based technologies for exosome research. Compared with traditional antibodies, aptamers offer higher stability, batch-to-batch consistency, and greater flexibility for custom development, making them suitable for exosome capture, detection, quantification, and analysis.
By targeting key exosome markers such as CD9, CD63, and CD81, these tools allow researchers to evaluate purification efficiency and support applications ranging from basic research to process development and biomarker discovery.
Building a Comprehensive Regenerative Medicine Research Ecosystem
From cell culture and 3D model development to exosome purification and analytical validation, LIS TECH and GeniCore Biotech jointly provide an integrated biomedical research solution. This platform enables researchers to Establish more stable, reproducible, and high-quality experimental workflows.
Both companies will continue to introduce innovative technologies and products, working together to advance regenerative medicine, exosome research, and next-generation biomedical innovation, while fostering new opportunities for collaboration within Taiwan’s biotech industry.
Contact Information
LIS TECH CO., LTD. & GeniCore Biotech Co., Ltd.
Website: https://www.lis-bio.com/zh-TW
Tel: +886-2-2228-8950
Email: info@lis-tek.com
Booth No.: M1231
More Exhibitor's Press Release
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08
- Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology and Expands Strategic LONZA / 2026-07-08